1. oxbum49791
2. latinoboyz4874
3. rpereira07
4. MamisTrist
5. franklola4509
1.WalkingDeader 01/26/2018
UPGRADES SOON - Reports of EPS beat ranging from $0.02 to $0.04. Beats on revenues.
2.813kimd 02/18/2018
Novartis AG is preparing to sell its U.S. generic pill business,
3.WalkingDeader 01/22/2018
Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period
4.rpereira07 01/25/2018
Wow!! ... More Awesome news for $NVS
5.MamisTrist 01/22/2018
Good stuff!
6.oxbum49791 01/18/2018
Superiority of Cosentyx® versus Stelara®* in achieving skin clearance for psoriasis patients
7.813kimd 01/29/2018
FDA Approval for Lutathera
8.rpereira07 01/26/2018
Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss
9.franklola4509 05/06/2018
FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer
10.MamisTrist 04/16/2018
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW